ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.3542
2.62%
Brent Oil
79.335
-0.68%
Bitcoin
69,114.58
-2.33%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Relay Therapeutics Inc (RLAY)

  7. Relay Therapeutics Inc (RLAY) Noticias

RLAY

Relay Therapeutics (RLAY)

Relay Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RLAY
FechaHoraFuenteTítuloSímboloCompañía
06/06/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
06/06/202406:00GlobeNewswire Inc.Relay Therapeutics Discloses Three New Programs at New Program & Platform EventNASDAQ:RLAYRelay Therapeutics Inc
05/06/202419:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
05/06/202415:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLAYRelay Therapeutics Inc
05/06/202415:05GlobeNewswire Inc.Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608NASDAQ:RLAYRelay Therapeutics Inc
21/05/202415:05GlobeNewswire Inc.Relay Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
13/05/202407:30GlobeNewswire Inc.Relay Therapeutics to Host New Program and Platform Event on June 6, 2024NASDAQ:RLAYRelay Therapeutics Inc
02/05/202415:05GlobeNewswire Inc.Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
25/04/202415:05GlobeNewswire Inc.Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024NASDAQ:RLAYRelay Therapeutics Inc
26/02/202415:05GlobeNewswire Inc.Relay Therapeutics to Participate in Three Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
22/02/202415:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RLAYRelay Therapeutics Inc
22/02/202415:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RLAYRelay Therapeutics Inc
22/02/202415:05GlobeNewswire Inc.Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
15/02/202415:05GlobeNewswire Inc.Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024NASDAQ:RLAYRelay Therapeutics Inc
01/02/202415:05GlobeNewswire Inc.Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:RLAYRelay Therapeutics Inc
10/01/202408:22Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RLAYRelay Therapeutics Inc
10/01/202408:14Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RLAYRelay Therapeutics Inc
08/01/202406:00GlobeNewswire Inc.Relay Therapeutics Announces $30 Million Private Placement FinancingNASDAQ:RLAYRelay Therapeutics Inc
02/01/202415:05GlobeNewswire Inc.Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RLAYRelay Therapeutics Inc
07/11/202315:05GlobeNewswire Inc.Relay Therapeutics to Participate in Stifel 2023 Healthcare ConferenceNASDAQ:RLAYRelay Therapeutics Inc
02/11/202315:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLAYRelay Therapeutics Inc
02/11/202315:05GlobeNewswire Inc.Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
26/10/202315:05GlobeNewswire Inc.Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023NASDAQ:RLAYRelay Therapeutics Inc
12/10/202315:05GlobeNewswire Inc.Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid TumorsNASDAQ:RLAYRelay Therapeutics Inc
18/09/202315:05GlobeNewswire Inc.Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:RLAYRelay Therapeutics Inc
08/08/202315:02GlobeNewswire Inc.Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
01/08/202315:05GlobeNewswire Inc.Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023NASDAQ:RLAYRelay Therapeutics Inc
28/06/202316:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RLAYRelay Therapeutics Inc
01/06/202317:22Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:RLAYRelay Therapeutics Inc
31/05/202315:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RLAYRelay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLAY

Su Consulta Reciente

NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
USOTC
BASFY
BASF (QX)
CCOM
OILBRENT
Brent Oil
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados